MedPath

Clinical trial on Fungal infections

Phase 4
Not yet recruiting
Conditions
Other specified local infections of the skin and subcutaneous tissue,
Registration Number
CTRI/2023/11/060215
Lead Sponsor
Government Siddha Medical College
Brief Summary

Among many patients attending skin special OPD, a significant number falls under Tinea

infectios, so it is the need of an hour to provide a better choice for them.

Padarthamarai perunoi (Tinea cruris and Tinea corporis) will be effectively treated with

the selected trial drugs.

It will be beneficial to the society by availing this trial medicines in skin special OPD.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Patients with the clinical features of pruritus with well dermarcated circumscribed mild erythematous annular scaly plaques with raised edges and central clearing on the body.
  • Especially affecting the groin, initially appearing along the crural fold,pubic region and adjacent thighs and extend outwards (Tinea cruris) / Appearing over the trunk of the body (Tinea corporis).
Exclusion Criteria

Tinea infections other than Tinea cruris and corporis Pregnant and lactating women Individuals those who are under immunosuppressive drugs Known HIV infected individuals Known patients of uncontrolled diabetes mellitus (Hba1c >9).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tinea infections will be effectively treated by the trial drugs12weeks
Secondary Outcome Measures
NameTimeMethod
Clinical features of Tinea infections will be effectively reduced when treated with external application of Nilaavarai gel6months

Trial Locations

Locations (1)

Government Siddha Medical College

🇮🇳

Chennai, TAMIL NADU, India

Government Siddha Medical College
🇮🇳Chennai, TAMIL NADU, India
DrJSamoogaNeethi
Principal investigator
7667778917
dr.samooganeethi@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.